statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript

Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical...

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a clinical stage specialty pharmaceutical company focused on rare and orphan...

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers...

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers

ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a specialty pharmaceutical company focused on rare and orphan diseases, today...

Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers...

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers

Titoli in rialzo
Il titolo Quoin Pharmaceuticals (NASDAQ:QNRX) salito del 129,59% a 6,36 dollari durante la sessione pre-market di luned .
Le azioni di Renalytix (NASDAQ:RNLX) hanno guadagnato il...

12 titoli sanitari in movimento, pre-market del 04/03/2024

Acciones al alza
Quoin Pharmaceuticals (NASDAQ:QNRX) crecieron un 129,95% para establecerse en los 6,37 d lares durante la sesi n del pre-market del lunes.
Ainos (NASDAQ:AIMD) experimentaron un...

12 acciones de salud en movimiento durante la preapertura del 04/03/2024

Clearance to include teen patients in both the company's open label and placebo controlled studies expected to significantly expand the number of eligible subjects, potentially expedite recruitment...

Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies

LAS VEGAS, NV / ACCESSWIRE / February 14, 2024 / Skinvisible, Inc. ('Skinvisible') (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin...

Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Volume	161,352.00
52-Wk High	$12.00
52-Wk Low	$0.6029

QNRX Quoin Pharmaceuticals Ltd - ADR

About

Feed

News

Sentiment

Fundamentals